Breast Cancer Ongoing Research (Part 1)
Weiping Tang, PhD, Professor and Clinical Instructor, School of Pharmacy/Pharmacy and Academic Affairs will present on “Development of Selective Small Molecule Degraders for Cancer-Causing Proteins.”
Suzanne Ponik, PhD, Senior Scientist and Asst. Faculty Assoc., School of Medicine & Public Health will present on “The Extracellular Matrix and Breast Cancer Progression.”
Medical oncologists, surgical oncologists, radiation oncologists, primary care physicians, RN’s, oncology nurses, nurse practitioners, clinical research associates, and other health care professionals involved in cancer care.
As a result of this educational activity, learners will be able to:
- Demonstrate the importance of extracellular matrix organization and composition in the breast tumor microenvironment.
- Demonstrate that TACS-3 collagen organization in invasive ductal carcinoma is prognostic of poor patient survival.
- Describe a new modality for small molecule drug discovery.
It is the policy of the University of Wisconsin–Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during the educational activity. For this educational activity all conflicts of interests have been resolved and detailed disclosures are listed below:
Click here to view the Planning Committee Disclosures.
Jessica Carlucci-Jenkins, BA: No relevant relationships to disclose in regard to this activity.
Kim Sprecker: No relevant relationships to disclose in regard to this activity.
* The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
Disclosure of Unlabeled Use: The University of Wisconsin–Madison ICEP advises the participant that this continuing medical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
Accreditation Council for Pharmacy Education (ACPE)
A maximum of 1 hour of knowledge-based CE credit can be earned by successfully completing this enduring activity. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. CE credit information, based on verification of success completion of a post test, will be provided to NABP within 60 days after the activity completion.
2020 Universal Activity Number (UAN):
American Medical Association
The University of Wisconsin–Madison ICEP designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this enduring activity for a maximum of 1 ANCC contact hour.
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for .01 continuing education units (CEUs) or 1 hour.
- 1.00 ACPE Contact Hours - Pharmacist
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™